100% agree. Revenue streams are already in place and are about to massively expand. The only questions are offtakes and sales for products which should both come as we will provide the highest of quality products and undercut the market at a profit. They also have a fully licenced processing facility to process other's cannabis and hemp for revenue.
The other question is funding until revenue covers the spend. This is already not too far off with THC and Canndeo products becoming available. There is no reason i know of that THC won't be able to secure finance. They have two fully owned facilities to borrow against for short term cover if they even need to at all from this point.
Couldn't imagine why people would be selling ATM. IMO, I'm scrambling to save and buy a couple more but not over expose. While im cautious - i can see an ongoing success story here.
- Forums
- ASX - By Stock
- EPN
- Ann: ASX.THCO Options Update and Appendix 3B
Ann: ASX.THCO Options Update and Appendix 3B, page-9
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
Add EPN (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable